Page last updated: 2024-09-03

me 2303 and Experimental Neoplasms

me 2303 has been researched along with Experimental Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, S; Tsuruo, T; Yusa, K1
Sudo, Y; Sugimoto, Y; Takamori, R; Tsuruo, T; Yusa, K1

Other Studies

2 other study(ies) available for me 2303 and Experimental Neoplasms

ArticleYear
Antitumor activity of ME2303, a fluorine-containing anthracycline, against human tumors implanted in nude mice.
    Japanese journal of cancer research : Gann, 1989, Volume: 80, Issue:7

    Topics: Animals; Doxorubicin; Drug Tolerance; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Structure-Activity Relationship

1989
A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Cancer research, 1989, Oct-15, Volume: 49, Issue:20

    Topics: Animals; Doxorubicin; Drug Resistance; In Vitro Techniques; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Neoplasms, Experimental; Sarcoma, Experimental; Tumor Cells, Cultured

1989